IIGANN 2021 – Virtual Symposium, Prague September 21 - 23rd, 2021

The International IgA Nephropathy Network will hold the 16th International Symposium on IgA Nephropathy 21–23 September 2021 and George Clinical scientific leader Professor Jonathan Barratt will present a key presentation during the first plenary session of the event.

Barratt, the Mayer professor of renal medicine at the University of Leicester, will present “RNA Interference in IgAN” on the first day of the conference which will be held virtually. The main topics of the symposium will be pathogenesis, pathology and treatment of IgA nephropathy. Special attention will be paid to discussing various pathogenetic mechanisms of IgA nephropathy targeted in ongoing randomized controlled trials. The network believes that with the expansion of therapeutic options, the outcome of patients with progressive IgA nephropathy will significantly improve. In addition to professional lectures and satellite symposia, there will also be poster sessions dedicated to the original communications. Partners such as George Clinical may also participate through a virtual exhibition. Register for the symposium here.

 

Read the full article here:

Scientific Leader Headlines George Clinical Involvement with IIGANN 2021

 

George Clinical's Leadership in Attendance

Professor Barratt’s research is focused on pathogenesis of IgA nephropathy and a range of areas across renal medicine including glomerular disease, multi-system renal disease and complications of chronic kidney disease, in particular renal associated anaemia. He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases and leads the Renal Research Group within the College of Life Sciences, University of Leicester. He also participates in other IgA nephrology  initiatives such as the International IgA Nephropathy Network and in workgroups identifying endpoints for clinical trials such as the FDA and ASN Kidney Health Initiative.

Professor Barratt has been Principal Investigator for international randomized controlled clinical trials in IgA nephropathy and has attended both the FDA and EMA as an expert witness for new therapies in IgA nephropathy. He is an Editorial Board member for Kidney International and Clinical Journal of the American Society of Nephrology and sits on the Kidney Research UK Grants committee. 

Event Location


Attending this event?

Meet with George Clinical! Contact us to schedule a time now.

    I agree to the handling of my personal information in accordance with the George Clinical privacy policy.

    Please input this code: captcha